Basics Celcuity Inc. Common Stock Celcuity Inc is a cellular analysis company. The company is discovering new cancer sub-types and commercializing diagnostic tests. IPO Date: September 20, 2017 Sector: Healthcare Industry: Medical Diagnostics & Research Market Cap: $408.67M Activated in VL: True Average Daily Range Avg Daily Range: $0.41 | 2.97% Avg Daily Range (30 D): $0.29 | 3.00% Avg Daily Range (90 D): $0.34 | 3.17% Institutional Daily Volume Avg Daily Volume: .07M Avg Daily Volume (30 D): .26M Avg Daily Volume (90 D): .21M Trade Size Avg Trade Size (Sh.): 80 Avg Trade Size (Sh.) (30 D): 68 Avg Trade Size (Sh.) (90 D): 65 Institutional Trades Total Inst.Trades: 265 Avg Inst. Trade: $2.2M Avg Inst. Trade (30 D): $1.01M Avg Inst. Trade (90 D): $1.3M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.42M Avg Closing Trade (30 D): $.72M Avg Closing Trade (90 D): $1.2M Avg Closing Volume: 160.59K         News Feb 27, 2025 @ 3:04 PM Oncology Breakthroughs: How Cancer Research Is Adv... Source: Prnewswire Jun 3, 2024 @ 8:01 PM Celcuity To Participate in Jefferies Global Health... Source: Celcuity Inc. May 30, 2024 @ 11:36 AM Celcuity Announces Pricing of Underwritten Common ... Source: Celcuity Inc. May 30, 2024 @ 11:00 AM Celcuity Inc. Announces Plan to Initiate a Phase 3... Source: Celcuity Inc. May 15, 2024 @ 8:01 PM Celcuity Inc. Reports First Quarter Financial Resu... Source: Celcuity Inc. Financials   TTM Q4 2024 FY 2024 Basic EPS $-2.83 $-.87 $-2.83 Diluted EPS $-2.83 $-.87 $-2.83 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -111.78M $ -36.65M $ -111.78M Operating Income / Loss $ -113.27M $ -36.43M $ -113.27M Cost of Revenue $ $ $ Net Cash Flow $ -8.15M $ 9.91M $ -8.15M PE Ratio